Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase II Trial - Breast Cancer Chemoprevention by Lovastatin

This study has been terminated.
(Slow accrual)
Information provided by (Responsible Party):
James Ford, Stanford University Identifier:
First received: January 31, 2006
Last updated: June 5, 2014
Last verified: June 2014